FDA Reports 2 More Contaminated NECC Drugs
The FDA has reported the presence of bacteria in two additional drugs manufactured and distributed from the New England Compounding Center in Framingham, Mass., according to an AHA News Now report.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Contamination was found in three lots of injectable betamethasone and one lot of cardioplegia solution. So far, the federal government has not reported any infections linked to these lots and is not changing its recommendations for diagnosing and treating patients who have received NECC products.
Over the course of the last several months, federal agencies have confirmed contaminated epidural steroid injections manufactured at NECC are linked to a meningitis outbreak that has injected hundreds of patients and killed 29.
More Articles on Patient Safety:
NQF Endorses Neurology, Behavioral Health Measures
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the free Becker's Operating Room Clinical Quality & Infection Control
E-Weekly, which focuses on clinical quality, infection control, patient safety and accreditation, click here.
Latest Articles
- House Votes to Repeal the PPACA — for 37th Time
- 6 Statistics on Concierge and Direct Pay Physician Practices
- Best Practices: Documentation and Reporting for Post-Operative Pain Management Procedures in Anesthesia
- 5 Things to Know About Medical Office Visits in 2012
- Medical Facilities Corporation Reports Higher Revenue After Arkansas Surgical Hospital Acquisition
